title: Phase I-II study of high-dose etoposide in patients with refractory breast cancer.
authors.affiliation: Department of Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston.
authors.forename: G
authors.initials: G
authors.lastname: Fraschini
authors.forename: F A
authors.initials: FA
authors.lastname: Holmes
authors.forename: L
authors.initials: L
authors.lastname: Esparza
authors.forename: R L
authors.initials: RL
authors.lastname: Theriault
authors.forename: A U
authors.initials: AU
authors.lastname: Buzdar
authors.forename: G N
authors.initials: GN
authors.lastname: Hortobagyi
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy*; D004341:Drug Evaluation; D005047:Etoposide / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans
chemical_list: D005047:Etoposide